John Neis, a director at Cellectar Biosciences ($CLRB), made one open market sale of company shares in the last year, totaling $732 on December 12, 2025. This places him 11,561st among 11,678 insiders by sale value, well below the average of $8.6 million across 6.4 transactions per insider. He reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 12, 2025 | Cellectar Biosciences, Inc. | $CLRB | NEIS JOHN | Director | S | Common Stock | 198 | $3.70 | 10.0000 | 3,162,040 | 95.19% | 0.01% |
| Feb. 14, 2025 | Cellectar Biosciences, Inc. | $CLRB | NEIS JOHN | Director | A | Stock option (right to buy) | 60000 | $0.00 | 60,000.0000 | 1,238,125 | 9999.99% | 4.85% |
| June 14, 2024 | Cellectar Biosciences, Inc. | $CLRB | NEIS JOHN | Director | A | Stock option (right to buy) | 60000 | $0.00 | 60,000.0000 | 29,346,679 | 9999.99% | 0.20% |
| June 28, 2023 | Cellectar Biosciences, Inc. | $CLRB | NEIS JOHN | Director | A | Stock option (right to buy) | 25000 | $0.00 | 47,887.0000 | 11,261,217 | 109.23% | 0.22% |